These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15311156)

  • 21. Platelet aggregability and occurrence of restenosis following coronary angioplasty.
    Goel PK; Shahi M; Agarwal AK; Srivastava S; Seth PK
    Int J Cardiol; 1997 Aug; 60(3):227-31. PubMed ID: 9261632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?
    Mickelson JK; Lakkis NM; Villarreal-Levy G; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1996 Aug; 28(2):345-53. PubMed ID: 8800108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase expression in the coronary circulation induced by coronary angioplasty.
    Hojo Y; Ikeda U; Katsuki Ta; Mizuno O; Fujikawa H; Shimada K
    Atherosclerosis; 2002 Mar; 161(1):185-92. PubMed ID: 11882331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty.
    Bach R; Jung F; Kohsiek I; Ozbek C; Spitzer S; Scheller B; Dyckmans J; Schieffer H
    Thromb Res; 1994; 74 Suppl 1():S55-67. PubMed ID: 8073402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of platelet-derived microparticles with C-C chemokines on vascular complication in patients with acute myocardial infarction.
    Matsumoto N; Nomura S; Kamihata H; Kimura Y; Iwasaka T
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):279-86. PubMed ID: 12361207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome.
    Nomura S; Uehata S; Saito S; Osumi K; Ozeki Y; Kimura Y
    Thromb Haemost; 2003 Mar; 89(3):506-12. PubMed ID: 12624635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.
    Inoue T; Sohma R; Miyazaki T; Iwasaki Y; Yaguchi I; Morooka S
    Am J Cardiol; 2000 Nov; 86(10):1057-62. PubMed ID: 11074199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
    Iuliano L; Praticò D; Greco C; Mangieri E; Scibilia G; FitzGerald GA; Violi F
    J Am Coll Cardiol; 2001 Jan; 37(1):76-80. PubMed ID: 11153776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA].
    Warzée F; Legrand V; Scheen AJ
    Rev Med Liege; 2004 Oct; 59(10):584-90. PubMed ID: 15623079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual platelet function under acetylsalicylic acid and the risk of restenosis after coronary angioplasty.
    Terres W; Hamm CW; Ruchelka A; Weilepp A; Kupper W
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):190-3. PubMed ID: 1376787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications of coronary angioplasty and stenting in 2003: what is left to surgery?
    Poyen V; Silvestri M; Labrunie P; Valeix B
    J Cardiovasc Surg (Torino); 2003 Jun; 44(3):307-12. PubMed ID: 12832982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.